Price on application
OnSite Rapid COVID Testing
The Onsite COVID-19 LGG/LGM is a lateral flow rapid test designed for initial screening by detecting anti-SARS-CoV-2 IgG and IgM antibodies in both human plasma, serum or whole blood within 15 minutes.
Each test requires minimally skilled personnel, meaning it’s extremely easy-to-use. The Onsite COVID-19 LGG/LGM test has 97.1 % sensitivity and 97.8% specificity, making this one of the most effective screening tests for COVID-19.
- Fingerprick device allows testing at point-of-care, saving crucial time
- Get results within just 15 minutes, allowing doctors to take immediate action of patient
- Complementary to PCR by detecting immune response